ASCIA‐P51: SAFETY OF 300IR 5‐GRASS POLLEN SUBLINGUAL TABLET FOR THE TREATMENT OF GRASS POLLEN‐INDUCED ALLERGIC RHINOCONJUNCTIVITIS IN ADULTS AND PEDIATRIC SUBJECTS WITH INTERMITTENT ASTHMA

Publisher： John Wiley & Sons Inc

E-ISSN： 1445-5994|46|S4|20-20

ISSN： 1444-0903

Source： INTERNAL MEDICINE JOURNAL, Vol.46, Iss.S4, 2016-09, pp. : 20-20

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Adverse Events During Immunotherapy Against Grass Pollen‐Induced Allergic Rhinitis – Differences Between Subcutaneous and Sublingual Treatment

By  

BASIC AND CLINICAL PHARMACOLOGY & TOXICOLOGY (ELECTRONIC), Vol. 117, Iss. 2, 2015-08 ,pp. : 73-84

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ultra‐short‐course booster is effective in recurrent grass pollen‐induced allergic rhinoconjunctivitis

By  

ALLERGY, Vol. 73, Iss. 1, 2018-01 ,pp. : 187-195

John Wiley & Sons Inc

Access to resources Recommend Favorite

ASCIA‐P47: 300IR SUBLINGUAL TABLET OF HOUSE DUST MITE ALLERGEN EXTRACTS: EFFICACY ON RHINITIS SYMPTOMS IN SUBJECTS WITH HOUSE DUST MITE‐ASSOCIATED ALLERGIC RHINITIS IN TWO PHASE III STUDIES

By  

INTERNAL MEDICINE JOURNAL, Vol. 46, Iss. S4, 2016-09 ,pp. : 19-19

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety of sublingual immunotherapy Timothy grass tablet in subjects with allergic rhinitis with or without conjunctivitis and history of asthma

By  

ALLERGY, Vol. 70, Iss. 3, 2015-03 ,pp. : 302-309

John Wiley & Sons Inc

Access to resources Recommend Favorite

An observational, real‐life safety study of a 5‐grass pollen sublingual tablet in children and adolescents

By  

PEDIATRIC ALLERGY AND IMMUNOLOGY, Vol. 25, Iss. 8, 2014-12 ,pp. : 760-766

John Wiley & Sons Inc

Access to resources Recommend Favorite